YP-008

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameYP-008
Drug Alias NameCyclopentenone Prostaglandin Mimetic (York Pharma)Natural-Defence-Prostanoid Mimetic (York Pharma)YP-008RPL-228
ClassificationSmall molecules
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsTumor necrosis factor α inhibitorsKeratinocytes inhibitors +[4] 
TargetsProstanoid receptorTumor necrosis factor αNuclear factor NF-kappa-B complex +[4] 
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRosanto Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRosanto Pharmaceuticals LtdYork Pharma plc
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A